Opioids

GPTKB entity

Statements (86)
Predicate Object
gptkbp:instanceOf gptkb:drug
gptkbp:broadcastOn Schedule I (heroin in US)
Schedule II (most opioids in US)
Schedule III (buprenorphine in US)
Schedule IV (tramadol in US)
gptkbp:cause gptkb:Euphoria
gptkb:Nausea
Addiction
Constipation
Tolerance
Respiratory depression
Physical dependence
gptkbp:enemyOf gptkb:Naltrexone
gptkb:Naloxone
gptkb:Alvimopan
gptkb:Methylnaltrexone
gptkb:Nalmefene
gptkbp:epidemic Opioid crisis
gptkbp:example gptkb:Codeine
gptkb:Heroin
gptkb:Buprenorphine
gptkb:Hydrocodone
gptkb:Hydromorphone
gptkb:Meperidine
gptkb:Morphine
gptkb:Oxycodone
gptkb:Tapentadol
gptkb:Tramadol
gptkb:Methadone
gptkb:Loperamide
gptkb:Oxymorphone
gptkb:Dextromethorphan
Fentanyl
gptkbp:historicalPeriod Used since ancient times
https://www.w3.org/2000/01/rdf-schema#label Opioids
gptkbp:legalStatus Controlled substance
gptkbp:mechanismOfAction Bind to opioid receptors
gptkbp:naturalVariants gptkb:Codeine
gptkb:Morphine
gptkbp:origin gptkb:Opium_poppy
gptkbp:overdoseTreatment gptkb:Naloxone
gptkbp:receptors gptkb:Delta_opioid_receptor
gptkb:Kappa_opioid_receptor
gptkb:Mu_opioid_receptor
gptkbp:regulates Prescription required
gptkbp:riskFactor gptkb:Overdose
Withdrawal symptoms
Substance use disorder
gptkbp:routeOfAdministration gptkb:Oral
Rectal
Intramuscular
Intravenous
Inhalation
Transdermal
Intranasal
Sublingual
gptkbp:semiSyntheticVariants gptkb:Hydrocodone
gptkb:Oxycodone
gptkbp:sideEffect gptkb:Hallucinations
gptkb:Bradycardia
Hypotension
Drowsiness
Dry mouth
Mood changes
Sexual dysfunction
Itching
Miosis
Endocrine dysfunction
Immune suppression
Impaired coordination
Suppressed cough reflex
Urinary retention
gptkbp:syntheticVariants gptkb:Methadone
Fentanyl
gptkbp:usedFor Pain management
Cough suppression
Diarrhea treatment
gptkbp:withdrawalSymptoms gptkb:Nausea
gptkb:Anxiety
gptkb:Insomnia
Vomiting
Sweating
Muscle aches
Diarrhea
gptkbp:bfsParent gptkb:Benzodiazepines
gptkbp:bfsLayer 6